SLN · Silence Therapeutics Plc ADR
United States · RS rating 99 · As of 2026-11-03
| Price | 19.78 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 99 / 96 / 97 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 49 / 75 / 60 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +18.2% |
| Sales growth Q/Q | -78.6% |
| Distance from 52-week high | +0.1% |
| Market cap (USD) | $370.3M |